JDD in the Media

Could You Be Allergic to Additives?

By December 30, 2019February 14th, 2020No Comments
A recent article from US News, “Could You Be Allergic to Additives?” cites a January 2013  JDD study  on whether common additives in food or medications can cause reactions in some people.
The study, “Medication Dyes as a Source of Drug Allergy,” states “Excipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or the kinetics of absorption, to improve stability, to influence palatability, or to create a distinctive appearance. The last function may depend heavily on the use of coloring agents, especially when there are multiple dosages (such as with warfarin), and dose confusion may result in profound complications. While described as inert, excipients have been associated with triggering immunological reactions, although this is almost never considered in common practice when patients have reactions to medications, even when they appear to react to many different and distinct drugs.”
Read Article Now

You May Also Like

Featured ArticlesJDD HighlightsJDD in the MediaThe Latest
July 31, 2023

WATCH VIDEO ABSTRACT: Assessing Implicit Bias in Dermatology

Click Here to Watch Video Abstract   Background: Patients with skin of color (SOC), defined as Fitzpatrick skin types IV to VI, and of varying ethnicities are under-represented in dermatology. This…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaSkin of ColorThe Latest
July 27, 2023

Dermatology Roundup: Racial Differences in Melanoma Survival Rates, ASA Announces Research Scholar Award Recipients

By Allison Sit A study published in the Journal of the American Academy of Dermatology found men with melanoma – and particularly men with skin of color – are more…
Featured ArticlesJDD HighlightsJDD in the MediaThe Latest
July 20, 2023

JDD in the News: Increased Dose of Adalimumab in Overweight, Obese Patients; Topical for Infantile Hemangiomas

Healio covered a JDD study on the impact of an increased dose of adalimumab in hidradenitis suppurativa patients who are overweight or obese. Researchers from the University of California San…

Leave a Reply